InvestorsHub Logo
Followers 54
Posts 6418
Boards Moderated 1
Alias Born 07/28/2015

Re: penny11 post# 112512

Thursday, 01/19/2023 2:43:05 AM

Thursday, January 19, 2023 2:43:05 AM

Post# of 113865
What are your thoughts?

FYI, no updates, no news, no study information, no FDA updates or approval, no SEC updates to sell their unregistered securities (they must be registered to sell or dilute and the SEC refused to review them), no patent update, no new insider buying/selling, no new institutional additions/departures/changes, and no update on their financial status (which is coming).

The SEC denied their acceleration requests, and in my opinion, they are a carbon copy of CytoDyn.

adva-27a may come back to haunt them as it was erroneously valued at 1 billion dollars.

SBFM-PL-4 appears to be abandoned and the FDA won't approve it and neither will the patent office (this got CytoDyn into trouble with the SEC for their covid claims).

adva-27a, their flagship, is nearing expiration and it has been denied approval by the FDA.

The recent acquisition of Nora is going to be a headache for SBFM if they run out of cash (they can't secure loans, dilute, or fundraise according to their November filing, which is related to the SEC).

Nora was a nothing company until March of 2022, when they bought a pharmaceutical plant. Net profit went from 150K to 350K. Still not much of a company. Revenue almost 11M, with 350K in net profit?

Companies combined, the net profit of SBFM is not even $1m. They have more than 3 employees now, they have an alleged pharmaceutical plant, and they will need operation cash to cover pay roll, HR, maintenance, working equipment, and the ability to buy supplies to manufacture generics, fish oil, and whey protein.

The company itself has nothing much to offer, they don't have any marketable patents or their own FDA approved pharmaceuticals. They can't even get to a phase 1 trial.

SBFM-PL-4 was not approved for a patent, only an *international* application number filed in May of 2021, 1 year after they stated they applied for FDA & patent acceleration back in May of 2020. This could be a problem for them as well as amended filings that generated a material impact, the lack of filing an 8-K for their "silent" so-called LNP partner, and so many other things.

There is not much proof that the plant is even operational, at what capacity, and what the last quarter sales (revenue & profit) are for Nora. And SBFM.

What I mentioned before, this company could pop because the O/S & float is around 22M. Half the insiders own nearly 50% of that 22M, so the actual number is less than 11M (float).

That's why I mentioned it could pop like Mt St Helens on no news. The bad news is very bad. It could crash just as quickly as it pops, or much much worse.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News